Publikationen von Peter H. Seeberger

Hofmann, K.; Reppe, K.; Parameswarappa, S.; Pereira, C.; Nouailles, G.; Bonin, A. v.; Klopfleisch, R.; Seeberger, P. H.; Witzenrath, M.: Eine semi-synthetische S. pneumoniae Serotyp 3 Tetrasaccharid-Konjugatvakzine schützt Mäuse vor Pneumonie. (2018)

Cavedon, C.; Gisbertz, S.; Vogl, S.; Richter, N.; Schrottke, S.; Teutloff, C.; Seeberger, P. H.; Thomas, A.; Pieber, B.: Photocatalyst-free, visible-light-mediated nickel catalyzed carbon–heteroatom cross-couplings. ChemRxiv (2021)

Seeberger, P. H.: How can vaccine design be modified by the use of synthetic sugars?, (2017)

Kamena, F.; Tamborrini, M.; Liu, X.; Kwon, Y.-U.; Thompson, F.; Pluschke, G.; Seeberger, P. H.: Synthetic GPI array to study antitoxic malaria response, Nature Chemical Biology 4, S. 238 - 240 (2008)

Noti, C.; Seeberger, P. H.: Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans, Chemistry & Biology 12, S. 731 - 756 (2005)

Seeberger, P. H.; Werz, D. B.: Automated synthesis of oligosaccharides as a basis for drug discovery, Nature Reviews Drug Discovery 4, S. 751 - 763 (2005)

Kolesar, J. M.; Seeberger, P. H.: Anticancer potential of Artemisia annua. Frontiers in Oncology 12 , 853406 (2022)

Koksch, B.; Seeberger, P. H.: Peptide Engineering Meeting 8. Peptide science 112 (1), e24146 (2020)

Koksch, B.; Seeberger, P. H.: Editorial overview: synthetic biomolecules: biopolymers. Current Opinion in Chemical Biology 40, S. A4 - A5 (2017)

Hicks, M. G.; Seeberger, P. H.; Seeberger, P. H.: The Beilstein Journal of Organic Chemistry and the changing face of scientific publishing. Beilstein Journal of Organic Chemistry 11, S. 2242 - 2244 (2015)

Seeberger, P. H.; Werz, D. B.: Glycochemistry and glycobiology: a web themed issue. Chemical Communications 47 (45), S. 12259 - 12259 (2011)

Seeberger, P. H.: Controlling science. ACS Chemical Biology 5 (7), S. 623 - 624 (2010)

Yin, J.; Hu, J.; Seeberger, P. H.; Qin, C.: Chemical synthesis method of plesiomonas shighelloides serotype O51 O-antigen oligosaccharide. (2019)

Seeberger, P. H.: Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide. (2019)

Yin, J.; Hu, J.; Seeberger, P. H.; Ye, Z.: Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation method. (2019)

Seeberger, P. H.: Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as vaccines against Haemophilus influenzae type b. (2018)

Seeberger, P. H.: Pneumococcal polysaccharide-protein conjugate composition. WO2017220753 (2018)

Seeberger, P. H.; Pereira, C. L.; Parameswarappa, S. G.; Calow, A. D. J.; Menova, P.; Baek, J. Y.: Improved preparation of vaccines against Streptococcus pneumoniae type 3. (2017)

Gilmore, K.; Seeberger, P. H.; Pieber, B.; Chatterjee, S.: Modular continuous flow device. (2017)

Khan, N.; Emmadi, M.: Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)